Clinical Trial Update: Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance [Phase 4]

View source ↗

Summary

Phase 4 trial completion evaluating tirofiban in patients with aspirin and/or clopidogrel resistance undergoing percutaneous transluminal coronary angioplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

Sponsor: Università degli Studi di Ferrara | Conditions: Angioplasty, Transluminal, Percutaneous Coronary | Phase 4 | Status: COMPLETED